Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
68.80    1.60 (2.38%)
Bid:
68.50
Ask:
68.80
Spread: 0.30 (0.438%)
Market Cap: $42.79b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Issue of Equity

18 Dec 2017 13:59

RNS Number : 6762Z
Axis Bank Limited
18 December 2017
 

AXIS/CO/CS/726/2017-18

18th December 2017

 

Dear Sir,

SUB: ALLOTMENT OF EQUITY SHARES AND WARRANTS ON A PREFERENTIAL BASIS

 

REF: REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENT) REGULATIONS 2015.

 

This has reference to our letters AXIS/CO/CS/597/2017-18 dated 10th November 2017 and AXIS/CO/CS/685/2017-18 dated 8th December 2017, wherein we had informed you regarding outcome of the Board Meeting held on 10th November 2017 and outcome of the Extraordinary General Meeting of the Shareholders of the Bank held on 8th December 2017, respectively.

 

We are pleased to inform that the Committee of Whole-time Directors of the Bank at its meeting held today has pursuant to receipt of the consideration, approved the issuance and allotment of:

 

· 5,56,00,000 equity shares of face value of Rs. 2/- each (the "Investor 1 Equity Shares") to BC Asia Investments VII Limited (the "Investor 1"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 3,19,00,000 equity shares of face value of Rs. 2/- each (the "Investor 2 Equity Shares") to Integral Investments South Asia IV (the "Investor 2"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 4,00,00,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 3 Convertible Warrants") to BC Asia Investments III Limited (the "Investor 3"), on a preferential basis at a price of Rupees 565 per warrant.

 

· 59,98,000 equity shares of face value of Rs. 2/- each (the "Investor 4 Equity Shares") to New World Fund, Inc. (the "Investor 4"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 2,26,884 equity shares of face value of Rs. 2/- each (the "Investor 5 Equity Shares") to Capital Group New World Fund (LUX) (the "Investor 5"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 53,08,000 equity shares of face value of Rs. 2/- each (the "Investor 6 Equity Shares") to American Funds Insurance Series - International Fund (the "Investor 6"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 4,28,72,967 equity shares of face value of Rs. 2/- each (the "Investor 7 Equity Shares") to EuroPacific Growth Fund (the "Investor 7"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 5,65,899 equity shares of face value of Rs. 2/- each (the "Investor 8 Equity Shares") to American Funds Insurance Series - International Growth and Income Fund (the "Investor 8"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 27,86,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 4 Convertible Warrants") to Investor 4, on a preferential basis at a price of Rupees 565 per warrant.

 

· 1,05,385 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 5 Convertible Warrants") to Investor 5, on a preferential basis at a price of Rupees 565 per warrant.

 

· 24,66,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 6 Convertible Warrants") to Investor 6, on a preferential basis at a price of Rupees 565 per warrant.

 

· 2,28,57,142 equity shares of face value of Rs. 2/- each (the "Promoter Investor Equity Shares") to Life Insurance Corporation of India (the "Promoter Investor"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

Pursuant to the allotment of the said equity shares, the total issued and paid up share capital of the Bank has increased from Rs. 479,71,01,600 (239,85,50,800 equity shares of Rs. 2/- each) to Rs. 512,77,59,384 (256,38,79,692 equity shares of Rs. 2/- each).

 

Please note that the Equity Shares allotted on a preferential basis as aforesaid rank pari passu with the existing equity shares of the Bank, in all respects.

 

Further, the equity shares and convertible warrants shall be under lock-in for such period as prescribed under the SEBI (Issue of Capital and Disclosures Requirement) Regulations, 2009.

 

You are requested to take note the above and arrange to bring it to the notice of all concerned.

 

Thanking you.

 

Yours Sincerely,

For Axis Bank Limited

 

 

 

Girish V Koliyote

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEGGGAAPUPMGWR
Date   Source Headline
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
22nd Nov 20232:22 pmRNSCredit Rating
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
1st Nov 20238:36 amRNSPostal Ballot Notice
26th Oct 20232:46 pmRNSPostal Ballot Voting Results
26th Oct 20231:35 pmRNSCessation
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
3rd Oct 20239:54 amRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
18th Aug 202311:17 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
28th Jul 20233:47 pmRNSVoting Results AGM
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023
17th Jul 20235:23 pmRNSReclassification of Promoter
11th Jul 20237:00 amRNSBoard Meeting Intimation
27th Jun 20234:12 pmRNSCredit Rating
26th Jun 202312:09 pmRNSNotice of Annual General Meeting and Annual Report
16th Jun 20231:53 pmRNSAppointment of Non-Executive (Part-time) Chairman
8th Jun 202311:24 amRNSPress Release
30th May 20233:44 pmRNSIntimation of Record date for Dividend
30th May 20233:40 pmRNSGrant of Stock Options
30th May 20233:30 pmRNSAppointment of Additional Independent Director
4th May 20231:49 pmRNSReclassification of Promoter
28th Apr 20233:39 pmRNSAmendment to Articles of Association
28th Apr 20233:25 pmRNSReclassification of Promoter
28th Apr 20233:20 pmRNSResults of Postal Ballot
28th Apr 202311:18 amRNSAppointment of Whole Time Director
27th Apr 20232:33 pmRNSRelated Party Transaction
27th Apr 20231:00 pmRNSInvestor Presentation and Press Release
27th Apr 202312:44 pmRNSBoard Meeting Outcome - Dividend and Fund Raising
27th Apr 202312:24 pmRNSOutcome of Board Meeting held on April 27, 2023
24th Apr 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
5th Apr 20231:49 pmRNSIntimation of Board Meeting on April 27, 2023
5th Apr 20237:00 amRNSCredit Rating
29th Mar 20232:49 pmRNSPostal Ballot Notice
27th Mar 20233:47 pmRNSDisclosure under Reg. 30 of SEBI (LODR) Reg. 2015
24th Mar 20232:32 pmRNSCredit Rating

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.